Halozyme Therapeutics shares owned by Carillon Tower Advisers
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Carillon Tower Advisers
from 13F filings
Historical chart of Carillon Tower Advisers investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Carillon Tower Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Carillon Tower Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2020-12-31 | $56M | 1.3M | 42.71 |
| 2020-09-30 | $36M | 1.4M | 26.28 |
| 2020-06-30 | $35M | 1.3M | 26.81 |
| 2020-03-31 | $17M | 1.1M | 16.32 |
| 2019-12-31 | $19M | 1.1M | 17.73 |
| 2019-09-30 | $16M | 1.1M | 15.51 |